Viemed Healthcare, Inc.
General ticker "VMD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $283.3M (TTM average)
Viemed Healthcare, Inc. follows the US Stock Market performance with the rate: 40.9%.
Estimated limits based on current volatility of 1.3%: low 9.48$, high 9.74$
Factors to consider:
- Total employees count: 1179 (+18.4%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Labor/talent shortage/retention, High capital expenditure requirements, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.09$, 10.20$]
- 2026-12-31 to 2027-12-31 estimated range: [6.71$, 11.09$]
Financial Metrics affecting the VMD estimates:
- Positive: with PPE of 20.0 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 18.04 > 12.90
- Positive: 7.54 < Operating profit margin, % of 7.66
- Positive: Inventory ratio change, % of 0.13 <= 0.78
- Negative: negative Industry operating cash flow (median)
- Negative: 0.01 < Interest expense per share per price, % of 0.41
- Negative: Industry earnings per price (median), % of -1.58 <= 0
- Positive: Shareholder equity ratio, % of 71.07 > 64.29
Short-term VMD quotes
Long-term VMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $182.36MM | $226.16MM | $270.28MM |
| Operating Expenses | $168.03MM | $208.26MM | $249.57MM |
| Operating Income | $14.33MM | $17.90MM | $20.71MM |
| Non-Operating Income | $0.06MM | $-1.73MM | $1.06MM |
| Interest Expense | $0.42MM | $0.78MM | $1.18MM |
| R&D Expense | $2.78MM | $3.07MM | $3.02MM |
| Income(Loss) | $14.39MM | $16.17MM | $21.77MM |
| Taxes | $4.15MM | $4.76MM | $6.39MM |
| Net Income(Loss)* | $10.24MM | $11.27MM | $14.93MM |
| Stockholders Equity | $113.89MM | $131.39MM | $141.54MM |
| Inventory | $4.63MM | $4.32MM | $5.05MM |
| Assets | $154.90MM | $177.07MM | $199.15MM |
| Operating Cash Flow | $45.21MM | $39.09MM | $51.92MM |
| Capital expenditure | $26.09MM | $37.77MM | $39.98MM |
| Investing Cash Flow | $-52.11MM | $-30.70MM | $-50.17MM |
| Financing Cash Flow | $2.83MM | $-3.69MM | $-5.79MM |
| Earnings Per Share** | $0.27 | $0.29 | $0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.